Andelyn Biosciences Revenue

Biotechnology Research • Upper Arlington, Ohio, United States • 201-500 Employees

Andelyn Biosciences revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$18,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,000,000
Total funding	$5,000,000

Overview Emails Format About Employees Insights Funding Tech Stack Trending Companies FAQ

Company overview

Headquarters	1180 Arthur E. Adams Dr., Columbus, Ohio 43221, US
Website	andelynbio.com
NAICS	541714
Keywords	Biotechnology, Gene Therapy, Research, Pharmaceuticals, Cdmo, Biological Sciences
Founded	2020
Employees	201-500
Socials

Andelyn Biosciences Email Formats

Andelyn Biosciences uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@andelynbio.com), used 51.4% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@andelynbio.com	51.4%
{first initial}.{last name}	j.doe@andelynbio.com	37%
{first name}.{last name}	john.doe@andelynbiosciences.com	10.4%

About Andelyn Biosciences

Andelyn Biosciences is a gene therapy CDMO dedicated to Turning Hope into Reality™. Our capabilities span viral vector process and analytical development, adherent and suspension based GMP drug substance manufacturing up to 2,000L, as well as GMP plasmid process development and GMP manufacturing. We are located in Columbus, OH, USA. With more than 20 years of pioneering experience in viral vector and vaccine manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders with extensive expertise. We have produced GMP material for over 75 worldwide clinical trials in addition to over 450 cGMP clinical batches and more than 2,000 research-grade productions. Andelyn provides research and tox grade plasmids with an additional offering of GMP plasmid manufacturing, advanced quality systems, full regulatory support, semi-automated to automated fill stations, and supply chain vertical integration. Our 180,000 sq ft clinical and commercial manufacturing facility comprises 16 upstream production suites for customization of new and tech transferred programs. Andelyn offers clinical through commercial-scale capabilities that will help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry

Senior

Manager

Employees by Department

Andelyn Biosciences has 112 employees across 14 departments.

Departments

Number of employees

Funding Data

Explore Andelyn Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-03-08	9	$5,000,000

Funding Insights

$5,000,000

Total funding amount

$5,000,000

Most recent funding amount

Number of funding rounds

Andelyn Biosciences Tech Stack

Discover the technologies and tools that power Andelyn Biosciences's digital infrastructure, from frameworks to analytics platforms.

6sense

Marketing automation

BugHerd

Issue trackers

Vimeo

Video players

Embedly

Widgets

Microsoft 365

Cloudflare

CDN

Salesforce Marketing Cloud Account Engagement

Marketing automation

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

Webflow

Page builders

Google Analytics

Analytics

Frequently asked questions

Andelyn Biosciences is located in Upper Arlington, Ohio, US.

Andelyn Biosciences generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Andelyn Biosciences has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Andelyn Biosciences was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Andelyn Biosciences has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.

Andelyn Biosciences has raised a total of $5,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Andelyn Biosciences

Wade Macedone

Chief Executive Officer

@andelynbio.com

4.8

40,000 users